Search

Displaying results 5961 - 5970 of 10000 in total
  1. Drug

    E-7820

    go.drugbank.com/drugs/DB12505
    Investigational

    E7820 has been investigated for the treatment of Colon Cancer and Rectal Cancer.

  2. Drug

    Apaziquone

    go.drugbank.com/drugs/DB12593
    Investigational

    Apaziquone has been investigated for the treatment of Bladder Cancer and Bladder Neoplasms.

  3. Drug

    Picropodophyllin

    go.drugbank.com/drugs/DB12802
    Investigational

    Picropodophyllin has been investigated for the treatment of Non Small Cell Lung Cancer.

  4. Drug

    Pancreatic Polypeptide

    go.drugbank.com/drugs/DB12822
    Investigational

    Pancreatic Polypeptide has been investigated for the treatment of Diabetes Mellitus, Type 1.

  5. Drug

    IOWH-032

    go.drugbank.com/drugs/DB12959
    Investigational

    Iowh032 has been investigated for the treatment of Cholera, Diarrhea, and Secretory Diarrhea.

  6. Drug

    Gestonorone

    go.drugbank.com/drugs/DB13230
    Experimental

    Gestonorone is often mistaken for gestonorone capproate which has a different chemical structure.

  7. Drug

    Pristimerin

    go.drugbank.com/drugs/DB17049
    Experimental

    Pristimerin is a quinone methide triterpenoid researched for its anti-cancer potential.[A253107]

  8. Drug

    ZKN-013

    go.drugbank.com/drugs/DB32582
    Experimental

    ZKN-013 is a readthrough inducer under investigation for rare dermatological diseases.[L56075]

  9. Drug

    Reproterol

    go.drugbank.com/drugs/DB12846
    Investigational

    Reproterol has been used in trials studying the treatment of Asthma, Exercise-Induced.

    Categories: Adrenergics for Systemic Use, Drugs for Obstructive Airway Diseases
  10. Drug

    Relutrigine

    go.drugbank.com/drugs/DB21614
    Investigational

    Relutrigine is under investigation in clinical trial NCT07010471 (A Clinical Trial for Participants With DEE to Assess Efficacy, Safety, Tolerability, and PK of Relutrigine). … Relutrigine is a small molecule drug. The usage of the INN stem '-trigine' in the name indicates that Relutrigine is a sodium channel blocker, signal transduction modulator.